Goldman Sachs
NPTN

Goldman Sachs’s NEOPHOTONICS CORP NPTN Stock Holding History

Goldman Sachs’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-230,000
Closed -$1.58M – 6137
2018
Q1 		$1.58M Buy
+230,000
New +$1.46M ﹤0.01% 3750

Other funds holding NPTN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Goldman Sachs's NPTN Position: Q3 2022 in Review

Goldman Sachs sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 1,689,218 shares — an estimated $26.6M sold.

Goldman Sachs first reported a position in NPTN in Q3 2013 and held it in 36 quarters. The position peaked at $26.6M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Goldman Sachs reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Goldman Sachs sold 1,689,218 NEOPHOTONICS CORP shares in Q3 2022, an estimated $26.6M.
  • Goldman Sachs first reported a position in NEOPHOTONICS CORP in Q3 2013 and held it in 36 quarters.
  • Goldman Sachs's NEOPHOTONICS CORP position peaked at $26.6M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.